openPR Logo
Press release

Investigation announced for Long-Term Investors in Outset Medical, Inc. (NASDAQ: OM) over potential Wrongdoing

10-14-2022 02:13 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Outset Medical, Inc. (NASDAQ: OM) shares.

An investigation on behalf of current long term investors in Outset Medical, Inc. (NASDAQ: OM) shares.

An investigation was announced for current long-term investors in shares of Outset Medical, Inc. (NASDAQ: OM) concerning potential breaches of fiduciary duties by certain directors of Outset Medical, Inc..

Investors who are current long term investors in Outset Medical, Inc. (NASDAQ: OM) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: OM stocks follows a lawsuit filed against Outset Medical, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: OM stocks, concerns whether certain Outset Medical directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the Defendants had "continuously made improvements and updates to Tablo over time since its original clearance" that required an additional 510(k) application, that as a result, the Company could not conduct a human factors study on a cleared device in accordance with FDA protocols, that the Company's inability to conduct the human factors study subjected the Company to the likelihood of the FDA imposing a "shipment hold" and marketing suspension, leaving the Company unable to sell Tablo for home use, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in Outset Medical, Inc. (NASDAQ: OM) over potential Wrongdoing here

News-ID: 2767255 • Views:

More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly NASDAQ: SINA)
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made. If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: FLR) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp. (NYSE: SOC)
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp. Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Outset

Caramanna, Friedberg LLP Represents Professionals from the outset of any Investi …
Image: https://www.globalnewslines.com/uploads/2025/07/1752223490.jpg Disciplinary proceedings before a regulatory tribunal can be highly stressful for the professional facing the allegations. This is because these kinds of proceedings can disrupt, suspend or terminate a professional's license to practice their profession. Thus, it is necessary for one to handle such matters with care and fastidious attention to detail. At Caramanna, Friedberg LLP, they can be of help, as their legal team has expertise in representing
Smart Dialysis System Market Growth Potential is Booming Now: Outset Medical, Me …
The latest study released on the Global Smart Dialysis System Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Smart Dialysis System market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the
Investigation announced for Long-Term Investors in shares of Outset Medical, Inc …
An investigation was announced for long-term investors in shares of Outset Medical, Inc. (NASDAQ: OM) concerning potential breaches of fiduciary duties by certain directors and officers of Outset Medical, Inc. Investors who are current long term investors in Outset Medical, Inc. (NASDAQ: OM) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors in shares of Outset Medical, Inc. (NASDAQ: OM)
An investor, who purchased shares of Outset Medical, Inc. (NASDAQ: OM), filed a lawsuit alleged violations of Federal Securities Laws by Outset Medical, Inc. Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and for certain investors are short and strict deadlines running. Deadline: September 6, 2022. NASDAQ: OM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. San Jose, CA based Outset
Investigation announced for Investors in shares of Outset Medical, Inc. (NASDAQ: …
An investigation was announced concerning potential securities laws violations by Outset Medical, Inc. in connection with certain statements. Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) concerning whether a series
Hemodialysis Catheter Market – Utilisation Survey 2025 | Toray Medical Co., Lt …
Global Hemodialysis Catheter Market: Overview Hemodialysis catheters are being extensively used to meet the growing demand of hemodialysis, apheresis, infusion, and monitoring of central venous pressure along with high-pressure contrast injection patients. It is predominantly used for maintaining effective blood flow rate, which is estimated at 400 ml/min for at least 3 hours. The growing number of patients suffering from end-stage renal disease (ESRD) have increased the demand for hemodialysis to